RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 92 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $162 | -99.8% | 5,581 | -78.4% | 0.00% | – |
| Q2 2022 | $107,000 | +143.2% | 25,890 | +564.0% | 0.00% | – |
| Q1 2022 | $44,000 | +33.3% | 3,899 | +16.5% | 0.00% | – |
| Q4 2021 | $33,000 | -63.7% | 3,348 | -24.0% | 0.00% | – |
| Q3 2021 | $91,000 | -9.9% | 4,404 | -15.4% | 0.00% | – |
| Q2 2021 | $101,000 | +1.0% | 5,204 | +10.3% | 0.00% | – |
| Q1 2021 | $100,000 | -67.0% | 4,716 | -53.8% | 0.00% | – |
| Q4 2020 | $303,000 | +194.2% | 10,200 | +113.2% | 0.00% | – |
| Q3 2020 | $103,000 | +472.2% | 4,785 | +295.8% | 0.00% | – |
| Q1 2020 | $18,000 | – | 1,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |